Jim Cramer's Latest Post

The Worst Companies Can M...

More Trading Strategies

By

Brian Nelson

 | Jul 28, 2014 | 6:00 PM EDT |
Altria's stake in SABMiller makes it one of the strongest income stocks.
By

Daniel Dicker

 | Jul 28, 2014 | 5:00 PM EDT |
A new Russian hegemony is being planned and executed.
By

James "Rev Shark" DePorre

 | Jul 28, 2014 | 4:24 PM EDT |
We could use some volatility to make it more interesting.
By

Roger Arnold

 | Jul 28, 2014 | 4:00 PM EDT |
The Trulia deal will create the one-stop shopping experience for real estate.
By

Jim Cramer

 | Jul 28, 2014 | 3:11 PM EDT |
Weak competitors are now serving as prime takeover targets.
By

Timothy Collins

 | Jul 28, 2014 | 3:00 PM EDT |
The best trend here will take some patience and following.
By

Tim Melvin

 | Jul 28, 2014 | 2:00 PM EDT |
The sector has been attracting attention from private equity investors for a while now.
By

Mike Norman

 | Jul 28, 2014 | 1:00 PM EDT |
Disregard the doom-and-gloom crowd and be ready to buy great stocks on the cheap.
By

Jim Cramer

 | Jul 28, 2014 | 12:33 PM EDT |
They want less politics and more guidance on companies that make money.
By

Sham Gad

 | Jul 28, 2014 | 12:00 PM EDT |
Amid the basket's impressive performance, I'm adding Minerva.
By

Eric Jackson

 | Jul 28, 2014 | 11:01 AM EDT |
The most dominant online real estate listing company in the continent emerges.
By

Kate Stalter

 | Jul 28, 2014 | 11:00 AM EDT |
That's what's dying -- not buy-and-hold.
By

Gary Dvorchak

 | Jul 28, 2014 | 10:30 AM EDT |
The large-cap rally is multiple-driven, and that makes me nervous.
By

Gary Berman

 | Jul 28, 2014 | 10:05 AM EDT |
The long-term buying zone is lower at $24.16-$23.38.
By

Brian Sozzi

 | Jul 28, 2014 | 10:00 AM EDT |
Despite the doomsayers, I'm not giving up on this rally just yet.

Upgrades & Downgrades

Bullish
Jul 28, 2014 | 8:37 AM EDT
TYC price target raised from $48 to $51, Barclays said. Overweight rating. Estimates also raised due to signs of non-res recovery and h…
Jul 28, 2014 | 8:36 AM EDT
MGLN price target lowered from $66 to $64, Barclays said. Equalweight rating. 2Q earnings reported lower than expected EPS and profit. …
Bullish
Jul 28, 2014 | 8:35 AM EDT
MCO price target raised from $100 to $104, Barclays said. Overweight rating. Estimates also raised following strong 2Q growth and well …
Bullish
Jul 28, 2014 | 8:34 AM EDT
UHS price target raised from $95 to $121, Barclays said. Overweight rating. Improved economy, larger positive impact from the ACA and s…
Jul 28, 2014 | 8:32 AM EDT
JBLU price target raised from $12 to $13. Equalweight rating. Domestic trends look stronger with lower fuel prices and better than expe…
I am still watching MON for a possible reversal against the time/price parameters. So far...
Market stages nice comeback from early losses to end basically flat. Gilead Sciences (GILD...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Cramer:  
DRI

Going to $47 without Otis...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.